CVS Health Corporation (CVS): More In-Depth Fundamental Analysis

CVS Health Corporation (NYSE:CVS) is one of the more popular stocks investors are adding into their watchlist. Now trading with a market value of 83.52B, the company has a mix of catalysts and obstacles that spring from the nature of its operations. In light of the many issues surrounding this company, we thought it was a good time to take a close look at the numbers in order to form a realistic perspective on the fundamental picture for this stock.

CVS Health Corporation (NYSE:CVS) Fundamentals That Matter

It’s generally a good idea to start with the most fundamental piece of the picture: the balance sheet. The balance sheet health of any company plays a key role in its ability to meet its obligations and maintain the faith of its investment base. For CVS, the company currently has 6.06 billion of cash on the books, which is offset by 6.13 billion in current liabilities. The trend over time is important to note. In this case, the company’s debt has been falling. The company also has 218.9 billion in total assets, balanced by 0 in total liabilities, which should give you a sense of the viability of the company under any number of imagined business contexts.

CVS Health Corporation saw 6 million in free cash flow last quarter, representing a quarterly net change in cash of 2.04 million. Perhaps most importantly where cash movements are concerned, the company saw about 7.29 million in net operating cash flow.

CVS Health Corporation (NYSE:CVS) Revenue Growth Potential

As far as key trends that demonstrate something of the future investment potential of this stock, we need to take a closer look at the top line, first and foremost. Last quarter, the company saw 63.43 billion in total revenues. That represents a quarterly year/year change in revenues of 0.26% in sequential terms, the CVS saw sales decline by 0.03%.

But what about the bottom line? After all, that’s what really matters in the end. CVS Health Corporation is intriguing when broken down to its core data. The cost of selling goods last quarter was 38.97 billion, yielding a gross basic income of 24.46 billion. For shareholders, given the total diluted outstanding shares of 1.31B, this means overall earnings per share of 1936000000. Note, this compares with a consensus analyst forecast of 1.74 in earnings per share for its next fiscal quarterly report.

Is CVS Health Corporation (NYSE:CVS) Valuation Attractive

Looking ahead at valuations, according to the consensus, the next fiscal year is forecast to bring about 7.19 in total earnings per share. However, one should always remember: the trends are more important than the forecasts. This continues to be an interesting story, and we look forward to updating it again soon on CVS Health Corporation.